Eosinophilic pneumonia CT

Revision as of 16:26, 9 February 2018 by Medhat (talk | contribs)
Jump to navigation Jump to search

Pneumonia Main Page

Eosinophilic pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eosinophilic pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Eosinophilic pneumonia CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eosinophilic pneumonia CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eosinophilic pneumonia CT

CDC onEosinophilic pneumonia CT

Eosinophilic pneumonia CT in the news

Blogs on Eosinophilic pneumonia CT

Directions to Hospitals Treating Eosinophilic pneumonia

Risk calculators and risk factors for Eosinophilic pneumonia CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

CT

  • At the onset of AEP, the chest radiograph may show only subtle reticular or ground glass opacities, often with Kerley B lines. [58,59]
  • As the disease progresses, bilateral diffuse mixed ground glass and reticular opacities develop [1,2,9,39-42,59] (image 1A-B).
  • Isolated ground glass (approximately 25 percent of cases) or reticular (approximately 25 percent of cases) opacities may also be seen on presentation. The distribution of opacities in AEP is diffuse, unlike chronic eosinophilic pneumonia, in which the opacities are typically localized to the lung periphery.
  • Small pleural effusions are common (noted in up to 70 percent of patients) and are frequently bilateral [8,45,48].
  • High resolution computed tomography (HRCT) scans are not essential to the diagnosis, but can help characterize the distribution of opacities and guide selection of an area of involvement for bronchoalveolar lavage. The HRCT is always abnormal in patients with AEP and is characterized by bilateral, random, and patchy ground-glass or reticular opacities (image 2) [19,60]. Centrilobular nodules and air-space consolidation are seen in approximately 50 and 40 percent, respectively [19].
  • In mild cases, the lesions are sparse or localized [41,61]. At the height of the disease process, HRCT reveals ground-glass opacities along the bronchovascular bundles. Pleural effusions, usually bilateral, are present in almost 90 percent.
  • bilateral ground-glass areas: common  
  • interlobular septal thickening: common
  • pleural effusions: can be present in ~80% (range 60-100%) of cases
  • thickening of bronchovascular bundles: present in around two-thirds of cases
  • air-space consolidation: present in around half of cases
  • ill-defined centrilobular nodules: present in around one-third of cases

Characteristic CT findings of CEP include:

  • bilateral consolidative opacities and areas of ground-glass attenuation, involving predominantly the peripheral regions of the middle or upper lung zones [43,61-63].
  • Common CT findings of ABPA consist of bronchiectasis, mucous plugging, bronchial wall thickening, atelectasis, consolidation, areas of ground-glass attenuation, and upper and central lung predominance [61]. The first three of these findings are the most indicative of ABPA.
  • CT findings in AEP include ground-glass attenuation, consolidation, poorly defined nodules, interlobular septal thickening, and pleural effusions (image 7). The triad of interlobular septal thickening, bronchovascular bundle thickening, and pleural effusions are most suggestive of this diagnosis [61].
  • CT findings in EGPA [64], drug-induced pulmonary eosinophilia [65], hypereosinophilic syndrome (HES), and simple pulmonary eosinophilia are varied and diverse. Thus, a radiologic diagnosis of these entities is rarely possible [61].

References

Template:WH Template:WS